GLP-1/glucagon dual agonistsGLP-1 / glucagon agonistAn incretin-receptor agonist that activates the GLP-1 (and sometimes glucagon/GIP) receptor, acting on metabolic and body-weight regulation.
Mazdutide vs Survodutide
The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.
 Mazdutide (IBI362) |  Survodutide | |
|---|---|---|
| What it is | GLP-1/glucagon dual agonist, registered in China | Glucagon/GLP-1 dual agonist, Boehringer/Zealand |
| Type | GLP-1 / glucagon dual agonist | Glucagon / GLP-1 dual agonist |
| Structure | Oxyntomodulin-based analog | Lipidated 29-aa glucagon analog |
| Status | Approved in China (2024) | Phase 3 |
| Route | SC, heti 1× | SC, heti 1× |
| Storage | 2–8°C | 2–8°C |
| Source | Placeholder, image later | Placeholder, image later |
| Full entry | Open → | Open → |
What it is
Mazdutide (IBI362)GLP-1/glucagon dual agonist, registered in China
SurvodutideGlucagon/GLP-1 dual agonist, Boehringer/Zealand
Type
Mazdutide (IBI362)GLP-1 / glucagon dual agonist
SurvodutideGlucagon / GLP-1 dual agonist
Structure
Mazdutide (IBI362)Oxyntomodulin-based analog
SurvodutideLipidated 29-aa glucagon analog
Status
Mazdutide (IBI362)Approved in China (2024)
SurvodutidePhase 3
Route
Mazdutide (IBI362)SC, heti 1×
SurvodutideSC, heti 1×
Storage
Mazdutide (IBI362)2–8°C
Survodutide2–8°C
Source
Mazdutide (IBI362)Placeholder, image later
SurvodutidePlaceholder, image later